Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats

Journal of Hypertension

Volumn 22, Issue 7, 2004, Pages 1333-1340

  Laakso, Juha T ^a   Teräväinen, Terttu Liisa ^a   Martelin, Eeva ^b   Vaskonen, Timo ^a   Lapatto, Risto ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Allopurinol; Hypertension; Kidney; Spontaneously hypertensive rat; Xanthine oxidoreductase

Indexed keywords

ALLOPURINOL; MESSENGER RNA; SODIUM; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH SODIUM INTAKE; KIDNEY HYPERTROPHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE;

EID: 3042788745     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000125441.28861.9f     Document Type: Article

References (36)

1. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38:1101-1106.
2. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282:F991-F997.
3. Sanchez-Lozada LG, Tapia E, Avila-Casado C, Soto V, Franco M, Santamaria J, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002; 283:F1105-F1110.
4. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41:1183-1190.
5. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34:144-150.
6. Selby J, Friedman G, Quesenberry JC. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131:1017-1027.
7. Prebis JW, Gruskin AB, Polinsky MS, Baluarte HJ. Uric acid in childhood essential hypertension. J Pediatr 1981; 98:702-707.
8. Laakso J, Mervaala E, Himberg JJ, Teräväinen TL, Karppanen H, Vapaatalo H, et al. Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension 1998; 32:902-906.
9. Laakso J, Vaskonen T, Mervaala E, Vapaatalo H, Lapatto R. Inhibition of nitric oxide synthase induces renal xanthine oxidoreductase activity in spontaneously hypertensive rats. Life Sci 1999; 65:2679-2685.
10. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, et al. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 1998; 95:4754-4759.
11. Wallwork CJ, Parks DA, Schmid-Schonbein GW. Xanthine oxidase activity in the dexamethasone-induced hypertensive rat. Microvasc Res 2003; 66:30-37.
12. Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol 2002; 19:640-653.
13. Iuchi T, Akaike M, Mitsui T, Ohsima Y, Shintani Y, Azuma H, et al. Glucocorticoid excess induces superoxide production in vascular endothelial dysfunction. Circ Res 2003; 92:81-87.
14. Zou AP, Cowley AW Jr. Role of nitric oxide in the control of renal function and salt sensitivity. Curr Hypertens Rep 1999; 1:178-186.
15. Ortiz P, Garvin J. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol Renal Physiol 2002; 283:F957-F962.
16. Grisk O, Kloting I, Exner J, Spiess S, Schmidt R, Junghans D, et al. Long-term arterial pressure in spontaneously hypertensive rats is set by the kidney. J Hypertens 2002; 20:131-138.
17. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002; 346:913-923.
18. Pfeffer KD, Huecksteadt TP, Hoidal JR. Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation. J Immunol 1994; 153:1789-1797.
19. Kayyali US, Donaldson C, Huang H, Abdelnour R, Hassoun PM. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J Biol Chem 2001; 276:14359-14365.
20. Linder N, Martelin E, Lapatto R, Raivio KO. Post-translational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions. Am J Physiol Cell Physiol 2003; 285:C48-C55.
21. Beckman JSD, Parks DA, Pearson JD, Marshall PA, Freeman B. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med 1989; 6:607-615.
22. Chirgwin J, Przybyla A, MacDonald R, Rutter W. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18:5294-5299.
23. Martelin E, Lapatto R, Raivio KO. Regulation of xanthine oxidoreductase by intracellullar iron. Am J Physiol Cell Physiol 2002; 283:C1722-C1728.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
25. Amaya Y, Yamazaki K, Sato M, Noda K, Nishino T. Proteolytic conversion of xanthine dehydrogenase from the NAD-dependent type to the O2-dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J Biol Chem 1990; 265:14170-14175.
26. Houston M, Estevez A, Chumley P, Aslan M, Marklund S, Parks DA, Freeman B. Binding of xanthine oxidase to vascular endothelium. J Biol Chem 1999; 274:4985-4994.
27. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 1991; 88:10045-10048.
28. Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res 2002; 90:297-304.
29. Horiuchi H, Ota M, Nishimura S, Kaneko H, Kasahara Y, Ohta T, et al. Allopurinol induces renal toxicity by impairing pyrimidine metabolism in mice. Life Sci 2000; 66:2051-2070.
30. Trachtman H, Valderrama E, Futterweit S. Nephrotoxicity of allopurinol is enhanced in experimental hypertension. Hypertension 1991; 17:194-202.
31. Suzuki Y, Sudo JI, Tanabe T. Allopurinol toxicity: its toxic organ-specificity between the liver and the kidney in the rat. J Toxicol Sci 1984; 9:343-351.
32. Vorbach C, Scriven A, Capecchi MR. The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland. Genes Dev 2002; 16:3223-3235.
33. Johnson RJ, Gordon K, Giachelli C, Kurth T, Skelton MM, Cowley AW Jr. Tubulointerstitial injury and loss of nitric oxide synthases parallel the development of hypertension in the Dahl-SS rat. J Hypertens 2000; 18:1497-1505.
34. Skov K, Nyengaard JR, Korsgaard N, Mulvany MJ. Number and size of renal glomeruli in spontaneously hypertensive rats. J Hypertens 1994; 12:1373-1376.
35. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995; 332:647-655.
36. Schurek HJ, Jost U, Baumgartl H, Bertram H, Heckman U. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol Renal Physiol 1990; 259:F910-F915.